Work

A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.tps4144

Authors: Kim Anna Reiss, Nita Ahuja, Stephen Baylin, Lauren Ann Mauro, Sheila Linden, Sharon White, Daniel A. Laheru, Joseph M. Herman, Christopher Lee Wolfgang, Matthew J. Weiss, John L. Cameron, Martin Makary, Nilofer Saba Azad

Institutions: Johns Hopkins University, George Washington University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601715129

Cites:

Cited by:

Related to: 10